Atlas Trials

Durvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer Patients Whose Disease is Limited to the Thorax

Clinical trial NCT05617963 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05617963
Sponsor
UNICANCER
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Small Cell Lung Carcinoma
Start date
2023-03-24
Primary completion
2028-02-24
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.